These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15384692)

  • 21. [Case of sporadic form of primary amyloidosis].
    Gulewicz E; Hulanicka K; Guzowski K
    Neurol Neurochir Pol; 1972; 6(5):885-8. PubMed ID: 4347946
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary amyloidosis (AL) as a cause of nephrotic syndrome.
    Bataille Y; Bovy C; Lancellotti P; Melchior V; Delbecque K; Beguin Y; Krzesinski JM
    Acta Clin Belg; 2005; 60(2):94-7. PubMed ID: 16082995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [AL amyloidosis].
    Gadó K; Domján G
    Orv Hetil; 2012 Apr; 153(15):563-73. PubMed ID: 22472357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects.
    Dubrey SW; Reece DE; Sanchorawala V; Hegenbart U; Merlini G; Palladini G; Fermand JP; Vescio RA; Bladé J; Heffner LT; Hassoun H; Liu X; Enny C; Ramaswami P; Elsayed Y; Van De Velde H; Mortimer S; Cakana A; Comenzo RL;
    QJM; 2011 Nov; 104(11):957-70. PubMed ID: 21752867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic amyloidosis, functional coronary insufficiency, and autonomic impairment.
    Capone R; Amsterdam EA; Mason DT; Zelis R
    Ann Intern Med; 1972 Apr; 76(4):599-603. PubMed ID: 4640319
    [No Abstract]   [Full Text] [Related]  

  • 26. [A less common cause of malabsorption syndrome].
    Sroubková R; Meisnerová E; Vítková I
    Cas Lek Cesk; 2003; 142(5):300-2. PubMed ID: 12920796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of nephrotic syndrome due to AA amyloidosis in psoriatic patients on long-term colchicine treatment. Case report and review of the literature.
    Kagan A; Husza'r M; Frumkin A; Rapoport J
    Nephron; 1999; 82(4):348-53. PubMed ID: 10450037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary systemic amyloidosis--a diagnostic primer.
    Gertz MA; Kyle RA
    Mayo Clin Proc; 1989 Dec; 64(12):1505-19. PubMed ID: 2513459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of nephrotic syndrome due to systemic AL amyloidosis after autologous stem cell transplantation: renal response is an important therapeutic end point.
    Akay OM; Sahin G; Kabukcuoglu S; Yalcin AU; Gulbas Z
    Clin Nephrol; 2008 Apr; 69(4):294-7. PubMed ID: 18397705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic diarrhea as the presenting feature of primary systemic AL amyloidosis: serendipity or delayed diagnosis?
    Wang C; Li Y; Jin Y; Zhou W; Zhu Y; Yao F; Qian J
    BMC Gastroenterol; 2013 Apr; 13():71. PubMed ID: 23617890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple myeloma presenting as malabsorption syndrome due to amyloidosis.
    Chakraborty SK; Chowdhury A; Kar S; Mondal S; Basu S; Ahmed AA
    J Assoc Physicians India; 2000 Sep; 48(9):931-2. PubMed ID: 11198801
    [No Abstract]   [Full Text] [Related]  

  • 32. Recovery of acute renal failure and nephrotic syndrome following autologous stem cell transplantation for primary (AL) amyloidosis.
    Snanoudj R; Mamzer-Bruneel MF; Hermine O; Grunfeld JP; Chauveau D
    Nephrol Dial Transplant; 2003 Oct; 18(10):2175-7. PubMed ID: 13679499
    [No Abstract]   [Full Text] [Related]  

  • 33. The best fit: do not discard AL amyloidosis too easily.
    Wessel H; Wiersinga WJ; Biemond BJ; Goorhuis A; Baars PA; Krediet CT
    Acta Clin Belg; 2015 Feb; 70(1):73-5. PubMed ID: 25310720
    [No Abstract]   [Full Text] [Related]  

  • 34. [Malabsorption syndrome and intestinal pseudoobstruction in primary vascular and heart amyloidosis].
    Schulz HJ; Reitzig P; Lisewski G; Dietze F
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(4):233-44. PubMed ID: 4792424
    [No Abstract]   [Full Text] [Related]  

  • 35. [Amyloid disease of the heart].
    Teodori MI
    Kardiologiia; 1972 Jan; 12(1):11-21. PubMed ID: 5016699
    [No Abstract]   [Full Text] [Related]  

  • 36. [Autonomic nerve disorders in generalized amyloidosis].
    Yazawa M; Ikeda S
    Nihon Rinsho; 1992 Apr; 50(4):818-26. PubMed ID: 1619766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective amyloidosis of the small intestine presenting as malabsorption syndrome.
    Harish K; Gokulan C
    Trop Gastroenterol; 2008; 29(1):37-9. PubMed ID: 18564667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical practice. Neurogenic orthostatic hypotension.
    Freeman R
    N Engl J Med; 2008 Feb; 358(6):615-24. PubMed ID: 18256396
    [No Abstract]   [Full Text] [Related]  

  • 39. A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis.
    Palladini G; Anesi E; Perfetti V; Obici L; Invernizzi R; Balduini C; Ascari E; Merlini G
    Br J Haematol; 2001 Jun; 113(4):1044-6. PubMed ID: 11442500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone.
    Wardley AM; Jayson GC; Goldsmith DJ; Venning MC; Ackrill P; Scarffe JH
    Br J Cancer; 1998 Sep; 78(6):774-6. PubMed ID: 9743299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.